SSC, Safe Save Medical Cell Sciences & Technology CO., Ltd was founded in 2011, engaged in the development of cancer immunotherapy, owns the technology of autologous Dendritic Cells/Tumor Antigens (ADCTA) immunotherapy, and develops autologous immune tailor made precision medicine, is the benchmark of immunotherapy industry in Taiwan.
Safe Save Cell adheres to the corporate philosophy of “R&D innovation, excellent quality and professional service”. Combining advanced research and development, technology platform, business model and Industry-Governor-Academia collaboration, Safe Save Cell established in Taiwan and are ambitious to be the global medicine provider and embark ourselves the leading company in dendritic cell immunotherapy in the world.
